Publications by authors named "Nazanin Tatari"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

273

Total Likes

15

Extended Reach

14,197

Social Features

6
C
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
Mathieu Seyfrid, William Thomas Maich, Vaseem Muhammad Shaikh, Nazanin Tatari, Deepak Upreti, Deween Piyasena, Minomi Subapanditha, Neil Savage, Dillon McKenna, Nicholas Mikolajewicz

J Immunother Cancer· January 2022

Videos about Article: user

1 5 2

View All Article and Social Media Activity
E
Embryonic Stem Cell Models of Human Brain Tumors.
Ludivine Coudière Morrison, Nazanin Tatari, Tamra Werbowetski-Ogilvie

Methods Mol Biol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Derived Glioblastoma Explants Empower Rapid and Personalized Drug Assessment: Harnessing the Potential of 3D Perfusion Bioreactors in Glioblastoma Drug Discovery.
Nazanin Tatari, Manuele G Muraro, Hayget Mohamed Seid Hedad, Gregor Hutter

Methods Mol Biol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma.
Michal Beffinger, Linda Schellhammer, Betül Taskoparan, Sereina Deplazes, Ulisse Salazar, Nazanin Tatari

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker.
Tomás A Martins, Deniz Kaymak, Nazanin Tatari, Fiona Gerster, Sabrina Hogan

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional profiling of murine glioma models highlights targetable immune evasion phenotypes.
Nicholas Mikolajewicz, Nazanin Tatari, Jiarun Wei, Neil Savage, Adrian Granda Farias

Acta Neuropathol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells.
Chirayu R Chokshi, Muhammad Vaseem Shaikh, Benjamin Brakel, Martin A Rossotti, David Tieu, Nazanin Tatari

Nat Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.
Philip Schmassmann, Julien Roux, Alicia Buck, Nazanin Tatari, Sabrina Hogan

Sci Transl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An HLA-G/SPAG9/STAT3 axis promotes brain metastases.
Blessing Iquo Bassey-Archibong, Chirayu Rajendra Chokshi, Nikoo Aghaei, Agata Monika Kieliszek, Nazanin Tatari

Proc Natl Acad Sci U S A· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers.
Nazanin Tatari, Shahbaz Khan, Julie Livingstone, Kui Zhai, Dillon Mckenna

Acta Neuropathol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma.
Maleeha A Qazi, Sabra K Salim, Kevin R Brown, Nicholas Mikolajewicz, Neil Savage, Nazanin Tatari

Cell Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time evaluation of a hydrogel delivery vehicle for cancer immunotherapeutics within embedded spheroid cultures.
Vincent Huynh, Nazanin Tatari, April Marple, Neil Savage, Dillon McKenna

J Control Release· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors.
Nazanin Tatari, Xiaoyu Zhang, Shawn C Chafe, Dillon McKenna, Keith A Lawson

Front Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.
David Bakhshinyan, Ashley A Adile, Jeff Liu, William D Gwynne, Yujin Suk, Nazanin Tatari

Sci Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Immunotherapy for Adult Glioblastoma.
Chirayu R Chokshi, Benjamin A Brakel, Nazanin Tatari, Neil Savage, Sabra K Salim

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma.
Nazanin Tatari, William T Maich, Sabra K Salim, Dillon Mckenna, Chitra Venugopal

STAR Protoc· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wnt activation as a therapeutic strategy in medulloblastoma.
Branavan Manoranjan, Chitra Venugopal, David Bakhshinyan, Ashley A Adile, Laura Richards, Nazanin Tatari

Nat Commun· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.
Parvez Vora, Chitra Venugopal, Sabra Khalid Salim, Nazanin Tatari, David Bakhshinyan

Cell Stem Cell· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells.
Branavan Manoranjan, Chirayu Chokshi, Chitra Venugopal, Minomi Subapanditha, Neil Savage, Nazanin Tatari

Oncogene· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Self-Renewal Assays for Brain Tumor Stem Cells.
Mathieu Seyfrid, David Bobrowski, David Bakhshinyan, Nazanin Tatari, Chitra Venugopal

Methods Mol Biol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embryonic Stem Cell Models of Human Brain Tumors.
Ludivine Coudière Morrison, Nazanin Tatari, Tamra E Werbowetski-Ogilvie

Methods Mol Biol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaphorin 3E Inhibits House Dust Mite-Induced Angiogenesis in a Mouse Model of Allergic Asthma.
Nazanin Tatari, Hesam Movassagh, Lianyu Shan, Latifa Koussih, Abdelilah S Gounni

Am J Pathol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD271 Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma.
Lisa Liang, Ludivine Coudière-Morrison, Nazanin Tatari, Margaret Stromecki, Agnes Fresnoza

Cancer Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.
Margaret Stromecki, Nazanin Tatari, Ludivine Coudière Morrison, Ravinder Kaur, Jamie Zagozewski

Mol Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemorepellent Semaphorin 3E Negatively Regulates Neutrophil Migration In Vitro and In Vivo.
Hesam Movassagh, Abeer Saati, Saravanan Nandagopal, Ashfaque Mohammed, Nazanin Tatari

J Immunol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis